The ongoing shortage of Amoxicillin has been deeply problematic for both healthcare providers and patients. As resupply delays have worsened the national shortage, Americans are reminded of the need for a trusted, reliable domestic source for this critical drug. 

Pharmaceutical company Novo Nordisk announced March 14 that it is lowering insulin prices by as much as 75 percent for diabetes patients.

Three out of 5 people who are at high risk for cardiovascular disease do not trust drugmakers, a recent study found. 

Drug shortages can happen for a plethora of reasons, but sometimes there's a "gap in knowledge" between manufacturers and regulatory agencies, according to FDA expert Emily Thakur. 

When Silicon Valley Bank collapsed March 10, Mark Cuban joined hundreds of tech company executives scrambling to recover funds and make payroll, but he considers himself lucky, according to Fortune.

No financial or clinical information was affected in January when "certain patients' names and email addresses were improperly shared" between Kroger's postal prescription service and its grocery business, the company said March 10. 

The Department of Veterans Affairs announced it will cover Leqembi, the Alzheimer's drug manufactured by Eisai  and Biogen, which received accelerated approval from the FDA in January, according to a March 13 company news release.

A $21 billion settlement between 46 attorneys general and three pharmaceutical distributors — AmerisourceBergen, Cardinal Health and McKesson — may be leading to more drug supply issues, The New York Times reported March 13. 

A growing number of patients taking Adderall, a drug for attention-deficit/hyperactivity disorder, are questioning whether the treatment works, The New York Times reported March 13. 

Shortages of several key drugs used in emergency department care continue to create difficulties for practitioners and patients. Pharmaceutical companies cite increased demand, supply issues and manufacturing delays as key reasons for the shortages. 

The American Society of Health-System Pharmacists named Samuel Calabrese, the chief pharmacy officer of Cleveland Clinic, to be its next vice president of accreditation services. 

New York Gov. Kathy Hochul and Attorney General Letitia James asked CVS, Walgreens and Rite Aid to promise they will sell the abortion medication mifepristone as other state attorneys general work to block the drug's distribution. 

The ongoing shortage of local anesthetics, including bupivacaine and lidocaine solutions, has been extended, drugmakers told the American Society of Health-System Pharmacists. 

Eli Lilly is halting development of solanezumab after it failed to slow cognitive decline in a study of patients at risk of Alzheimer's disease, the drugmaker said March 8. 

Duluth, Minn.-based Essentia Health announced new plans to open a 16,000-square-foot clinic and drive-through pharmacy in Staples, Minn.

Community health centers, healthcare advocacy groups and a pharmaceutical lobby created an alliance aimed at protecting 340B, a drug-pricing program for eligible hospitals. Hospitals aren't a fan of the alliance.

California Gov. Gavin Newsom withdrew a contract with Walgreens worth $54 million on March 8 after the national pharmacy chain shared conflicting plans for dispensing abortion pills. 

In a March 8 Twitter thread, the FDA acknowledged it's aware of a potential drug supply disruption after Gurnee, Ill.-based Akorn Operating Co. closed in late February. 

An ongoing national shortage of amoxicillin has again been further exacerbated by resupply delays.

Covis Pharma will stop selling Makena, the only FDA-approved drug to prevent preterm births, months after a panel voted 14-1 to retract the treatment, according to The Wall Street Journal.